Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143284 |
| CAS No | NA |
| Mol.F. | C15H11ClF2N4O4S |
| Mol.Wt. | 416.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143285 |
| CAS No | NA |
| Mol.F. | C15H12F2N4O4S |
| Mol.Wt. | 382.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143286 |
| CAS No | NA |
| Mol.F. | C15H12F2N4O8S2 |
| Mol.Wt. | 478.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143287 |
| CAS No | 82660-96-6 |
| Mol.F. | C26H44N2O8S |
| Mol.Wt. | 544.70 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143288 |
| CAS No | 76757-85-2 |
| Mol.F. | C23H36N2O7 |
| Mol.Wt. | 452.55 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143289 |
| CAS No | 158179-60-3 |
| Mol.F. | C2H4N2O3 |
| Mol.Wt. | 104.07 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143290 |
| CAS No | NA |
| Mol.F. | C3H8N2O4S |
| Mol.Wt. | 168.17 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143291 |
| CAS No | NA |
| Mol.F. | C9H12N4O2 |
| Mol.Wt. | 208.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143292 |
| CAS No | NA |
| Mol.F. | C13H15ClN4O3 |
| Mol.Wt. | 310.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143293 |
| CAS No | NA |
| Mol.F. | C28H36N8O3 |
| Mol.Wt. | 532.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143294 |
| CAS No | NA |
| Mol.F. | C22H25BrN8O2 |
| Mol.Wt. | 513.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143295 |
| CAS No | NA |
| Mol.F. | C22H26N8O2 |
| Mol.Wt. | 434.5 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143296 |
| CAS No | NA |
| Mol.F. | C9H11N5O3 |
| Mol.Wt. | 237.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143297 |
| CAS No | NA |
| Mol.F. | C32H42N8O5 |
| Mol.Wt. | 618.74 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143298 |
| CAS No | NA |
| Mol.F. | C24H28N8O2 |
| Mol.Wt. | 460.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143299 |
| CAS No | NA |
| Mol.F. | C25H28N8O4 |
| Mol.Wt. | 504.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |